Key result
Thoracic endovascular aortic repair (TEVAR) is a safe and successful therapy for chronic type B aortic dissection in patients for whom open repair presents significant morbidity and mortality.
Why the study?
Although TEVAR is the standard of care in acute complicated type B dissections, its role, technical feasibility, and outcomes in chronic type B aortic dissection remain controversial.
Does thoracic endovascular aortic repair (TEVAR) provide a safe and successful treatment alternative to open repair in patients with chronic type B aortic dissection?
Does thoracic endovascular aortic repair (TEVAR) provide a safe and successful treatment alternative to open repair in patients with chronic type B aortic dissection?
Answers are grounded in this paper and cite their sources.
TEVAR is increasingly recognized as a safe and technically feasible alternative to open repair for chronic type B aortic dissection, particularly in high-surgical-risk patients.
The most common indication for the management of chronic type B aortic dissection (cTBAD) is aneurysmal dilatation of the dissected segment which has been traditionally managed via open repair for patients who were optimal surgical candidates. With the rise in popularity of endovascular therapies, thoracic endovascular aortic repair (TEVAR) is increasingly offered to patients with cTBAD. Although TEVAR is the standard of care in acute complicated type B dissections, its role, technical feasibility and outcomes in cTBAD remain controversial. The reasons for such controversy are largely due to the presence of a thick dissection septum, the lack of suitable landing zones and the persistent false lumen flow preventing positive aortic remodeling in the chronic aortic pathology. Nevertheless, there is mounting evidence supporting that TEVAR is a safe and successful therapy in patients for whom an open approach presents significant morbidity and mortality. The present review describes the technical considerations in catheter-based treatment approaches and respective outcomes. We also will examine the large armamentarium of techniques that have made TEVAR a reliable option in cTBAD.
No takes yet. Share an insight, caveat, or question.
Fukuhara et al. (2021) conducted a review in Chronic type B aortic dissection (cTBAD). Thoracic endovascular aortic repair (TEVAR) vs. Open repair was evaluated. Thoracic endovascular aortic repair (TEVAR) is a safe and successful therapy for chronic type B aortic dissection in patients for whom open repair presents significant morbidity and mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: